{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/265969150"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In a preferred embodiment, the composition comprises a drug capable of modulating the specific binding of the GPCR with a ligand on a target cell. [0233] Antibodies [0234] Also, antibodies including both polyclonal and monoclonal antibodies, and drugs that modulate the production or activity of the modified GPCRs and/or their biologically active fragments or subunits may possess certain diagnostic" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "google.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/61104489"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/265969150"] } } }
